Whole blood gene expression profiles distinguish clinical phenotypes of venous thromboembolism

Thrombosis Research

Volumn 135, Issue 4, 2015, Pages 659-665

  Lewis, Deborah A ^a   Suchindran, Sunil ^b   Beckman, Michele G ^c   Hooper, W Craig ^c   Grant, Althea M ^c   Heit, John A ^d   Manco Johnson, Marilyn ^e   Moll, Stephan ^f   Philipp, Claire S ^g   Kenney, Kristy ^c   De Staercke, Christine ^c   Pyle, Meredith E ^c   Chi, Jen Tsan ^a   Ortel, Thomas L ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF COLORADO   (United States)

^f UNIVERSITY OF NORTH CAROLINA   (United States)

^g ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

deep vein thrombosis; gene expression profiling; venous thrombosis

Indexed keywords

KALLIKREIN; KALLIKREIN B1; LIPOCORTIN 5; MEMBRANE COFACTOR PROTEIN; PADGEM PROTEIN; UNCLASSIFIED DRUG; WARFARIN; TRANSCRIPTOME;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLOOD; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE ONTOLOGY; GENE PROBE; HIGH RISK PATIENT; HUMAN; IMMUNE RESPONSE; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; VENOUS THROMBOEMBOLISM; VERY ELDERLY; GENETICS; MIDDLE AGED; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; RISK FACTORS; TRANSCRIPTOME; VENOUS THROMBOEMBOLISM;

EID: 84924988178     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2015.02.003     Document Type: Article

References (43)

1. M.G. Beckman, W.C. Hooper, S.E. Critchley, and T.L. Ortel Venous thromboembolism: a public health concern Am J Prev Med 38 2010 S495 S501
2. J.A. Heit, M.D. Silverstein, D.N. Mohr, T.M. Petterson, W.M. O'Fallon, and L.J. Melton III Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study Arch Intern Med 160 2000 809 815
3. J.A. Heit, D.N. Mohr, M.D. Silverstein, T.M. Petterson, W.M. O'Fallon, and L.J. Melton III Predictors of Recurrence After Deep Vein Thrombosis and Pulmonary Embolism: A Population-Based Cohort Study Arch Intern Med 160 2000 761 768
4. T. Baglin, R. Luddington, K. Brown, and C. Baglin Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study Lancet 362 2003 523 526
5. M.A. Crowther, and J.G. Kelton Congenital thrombophilic states associated with venous thrombosis: a qualitative overview and proposed classification system Ann Intern Med 138 2003 128 134
6. C.R. Keenan, and R.H. White The effects of race/ethnicity and sex on the risk of venous thromboembolism Curr Opin Pulm Med 13 2007 377 383
7. C. Kearon, E.A. Akl, A.J. Comerota, P. Prandoni, H. Bounameaux, and S.Z. Goldhaber Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2012 e419S e494S
8. S. Schulman, P. Lindmarker, M. Holmstrom, G. Larfars, A. Carlsson, and P. Nicol Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months J Thromb Haemost 4 2006 734 742
9. I. Pabinger, and C. Ay Biomarkers and venous thromboembolism Arterioscler Thromb Vasc Biol 29 2009 332 336
10. P.A. Kyrle, F.R. Rosendaal, and S. Eichinger Risk assessment for recurrent venous thrombosis Lancet 376 2010 2032 2039
11. M. Verhovsek, J.D. Douketis, Q. Yi, S. Shrivastava, R.C. Tait, and T. Baglin Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism Ann Intern Med 149 2008 481 490 [w94]
12. P.A. Kyrle, G. Hron, S. Eichinger, and O. Wagner Circulating P-selectin and the risk of recurrent venous thromboembolism Thromb Haemost 97 2007 880 883
13. G. Hron, M. Kollars, B.R. Binder, S. Eichinger, and P.A. Kyrle Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation JAMA 296 2006 397 402
14. J. Kim, N. Ghasemzadeh, D.J. Eapen, N.C. Chung, J.D. Storey, and A.A. Quyyumi Gene expression profiles associated with acute myocardial infarction and risk of cardiovascular death Genome Med 6 2014 40
15. B.W. Higgs, Z. Liu, B. White, W. Zhu, W.I. White, and C. Morehouse Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway Ann Rheum Dis 70 2011 2029 2036
16. D.A. Lewis, G.J. Stashenko, O.M. Akay, L.I. Price, K. Owzar, and G.S. Ginsburg Whole blood gene expression analyses in patients with single versus recurrent venous thromboembolism Thromb Res 128 2011 536 540
17. C.M. Carvalho, J. Chang, J.E. Lucas, J.R. Nevins, Q. Wang, and M. West High-Dimensional Sparse Factor Modeling: Applications in Gene Expression Genomics J Am Stat Assoc 103 2008 1438 1456
18. H. Zou, and T. Hastie Regularization and variable selection via the elastic net J R Stat Soc Ser B Stat Methodol 67 2005 301 320
19. J. Friedman, T. Hastie, and R. Tibshirani Regularization Paths for Generalized Linear Models via Coordinate Descent J Stat Softw 33 2010 1 22
20. M. West, C. Blanchette, H. Dressman, E. Huang, S. Ishida, and R. Spang Predicting the clinical status of human breast cancer by using gene expression profiles Proc Natl Acad Sci U S A 98 2001 11462 11467
21. G.K. Smyth Linear models and empirical bayes methods for assessing differential expression in microarray experiments Stat Appl Genet Mol Biol 3 2004 [Article3]
22. N.F. Dowling, M.G. Beckman, M. Manco-Johnson, K. Hassell, C.S. Philipp, and L.A. Michaels The U.S. Thrombosis and Hemostasis Centers pilot sites program J Thromb Thrombolysis 23 2007 1 7
23. P. Du, W.A. Kibbe, and S.M. Lin lumi: a pipeline for processing Illumina microarray Bioinformatics 24 2008 1547 1548
24. R Development Core Team R: A Language and Environment for Statistical Computing 2012 R Foundation for Statisical Computing [http:www.R-project.org]
25. R. Bourgon, R. Gentleman, and W. Huber Independent filtering increases detection power for high-throughput experiments Proc Natl Acad Sci 107 2010 9546 9551
26. A.J. Hackstadt, and A.M. Hess Filtering for increased power for microarray data analysis BMC Bioinf 10 2009 11
27. T. Barrett, S.E. Wilhite, P. Ledoux, C. Evangelista, I.F. Kim, and M. Tomashevsky NCBI GEO: archive for functional genomics data sets - update Nucleic Acids Res 41 2013 D991 D995
28. R. Simon Guidelines for the Design of Clinical Studies for the Development and Validation of Therapeutically Relevant Biomarkers and Biomarker-Based Classification Systems G. Gasparini, D. Hayes, Biomarkers in Breast Cancer 2006 Humana Press 3 15
29. A.M. Molinaro, R. Simon, and R.M. Pfeiffer Prediction error estimation: a comparison of resampling methods Bioinformatics 21 2005 3301 3307
30. E.W. Steyerberg, F.E. Harrell Jr., G.J.J.M. Borsboom, M.J.C. Eijkemans, Y. Vergouwe, and J.D.F. Habbema Internal validation of predictive models: Efficiency of some procedures for logistic regression analysis J Clin Epidemiol 54 2001 774 781
31. W. Huang da, B.T. Sherman, and R.A. Lempicki Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources Nat Protoc 4 2009 44 57
32. W. Huang da, B.T. Sherman, and R.A. Lempicki Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists Nucleic Acids Res 37 2009 1 13
33. E. Grandone, G. Tiscia, D. Colaizzo, P. Vergura, D. Pisanelli, and M. Margaglione The haplotype M2 within the ANXA5 gene is independently associated with the occurrence of deep venous thrombosis Thromb Haemost 103 2010 1102 1103
34. J.A. Heit, J.M. Cunningham, T.M. Petterson, S.M. Armasu, D.N. Rider, and M. De Andrade Genetic variation within the anticoagulant, procoagulant, fibrinolytic and innate immunity pathways as risk factors for venous thromboembolism J Thromb Haemost 9 2011 1133 1142
35. C.E. Evans, J. Humphries, K. Mattock, M. Waltham, A. Wadoodi, and P. Saha Hypoxia and upregulation of hypoxia-inducible factor 1{alpha} stimulate venous thrombus recanalization Arterioscler Thromb Vasc Biol 30 2010 2443 2451
36. M.M. Markiewski, B. Nilsson, K.N. Ekdahl, T.E. Mollnes, and J.D. Lambris Complement and coagulation: strangers or partners in crime? Trends Immunol 28 2007 184 192
37. F. Lupu, R.S. Keshari, J.D. Lambris, and K. Mark Coggeshall Crosstalk between the coagulation and complement systems in sepsis Thromb Res 133 Suppl. 1 2014 S28 S31
38. W. Lv, L. Wang, Q. Duan, Z. Gong, F. Yang, and H. Song Characteristics of the complement system gene expression deficiency in patients with symptomatic pulmonary embolism Thromb Res 132 2013 e54 e57
39. P.F. Zipfel, S. Heinen, M. Jozsi, and C. Skerka Complement and diseases: defective alternative pathway control results in kidney and eye diseases Mol Immunol 43 2006 97 106
40. S.T. Van Bijnen, W.L. Van Heerde, and P. Muus Mechanisms and clinical implications of thrombosis in paroxysmal nocturnal hemoglobinuria J Thromb Haemost 10 2012 1 10
41. M. Cushman, E.S. O'Meara, A.R. Folsom, and S.R. Heckbert Coagulation factors IX through XIII and the risk of future venous thrombosis: the Longitudinal Investigation of Thromboembolism Etiology Blood 114 2009 2878 2883
42. L. Nie, G. Wu, D.E. Culley, J.C. Scholten, and W. Zhang Integrative analysis of transcriptomic and proteomic data: challenges, solutions and applications Crit Rev Biotechnol 27 2007 63 75
43. H. Wang, Q. Duan, L. Wang, Z. Gong, A. Liang, and Q. Wang Analysis on the pathogenesis of symptomatic pulmonary embolism with human genomics Int J Med Sci 9 2012 380 386